Financhill
Back

Alterity Therapeutics Stock Price Chart

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ATHE is experiencing selling pressure, which indicates risk of future bearish movement.

Alterity Therapeutics Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 1.17 Sell
20-day SMA: 1.17 Sell
50-day SMA: 1.24 Sell
200-day SMA: 1.68 Sell
8-day EMA: 1.16 Sell
20-day EMA: 1.18 Sell
50-day EMA: 1.26 Sell
200-day EMA: 1.68 Sell

Alterity Therapeutics Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.03 Sell
Relative Strength Index (14 RSI): 38.17 Sell
Chaikin Money Flow: -12175 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.15 - 1.23) Sell
Bollinger Bands (100): (1.16 - 1.66) Sell

Alterity Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Alterity Therapeutics Stock

Is Alterity Therapeutics Stock a Buy?

ATHE Technical Analysis vs Fundamental Analysis

Sell
22
Alterity Therapeutics (ATHE) is a Sell

Is Alterity Therapeutics a Buy or a Sell?

Alterity Therapeutics Stock Info

Market Cap:
9.66M
Price in USD:
1.11
Share Volume:
13.11K

Alterity Therapeutics 52-Week Range

52-Week High:
5.41
52-Week Low:
1.01
Sell
22
Alterity Therapeutics (ATHE) is a Sell

Alterity Therapeutics Share Price Forecast

Is Alterity Therapeutics Stock a Buy?

Fundamental Analysis of Alterity Therapeutics

Is Alterity Therapeutics a good investment?

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and an increase next year of $0.00 per share.

Technical Analysis of Alterity Therapeutics

Should I short Alterity Therapeutics stock?

* Alterity Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.